SAN FRANCISCO, April 17 /CNW/ -- Burrill & Company today announced that
Dr. Ganesh M. Kishore, PhD has joined the firm as Managing Director. Dr.
Kishore joins the company to focus on Burrill's activities in Malaysia, India,
and the AgBio, health and wellness, industrial biotech and biofuels sectors,
in addition to Burrill & Company's general life science focus.
"We are delighted to have Kish on board. His exceptional experience in
the agricultural, industrial biotech, biofuels and life sciences industry
particularly at the leading edge of research will be invaluable for our
Venture Group at Burrill," said G. Steven Burrill, CEO of Burrill & Company, a
San Francisco based global leader in life sciences, whose principal activities
are in Venture Capital, Merchant Banking and Media.
Prior to joining Burrill, Dr. Kishore served as Vice President, Science &
Technology and Chief Biotechnology Officer of DuPont. Prior to this he was the
Vice President, Technology, for DuPont Agriculture & Nutrition. He joined
DuPont in June of 2003 and has been focusing on R&D efforts related to
biotechnology within the company. Dr. Kishore previously served as Co-
President, Nutrition & Consumer Sector and Assistant Chief Scientist/Chief
Biotechnologist for Monsanto Company, which he joined in 1980.
His contributions include the discovery, development and
commercialization of ag-bio products, manufacturing processes for
Nutrasweet(R) and the transformation of a chemical giant into a leading food
and nutrition company. Dr. Kishore received a B.S.c in Physics and Chemistry,
an M.S.c in Biochemistry from the University of Mysore and a Ph.D. in
Biochemistry at the Indian Institute of Science and undertook Postdoctoral
Training at the University of Texas at Austin.
Dr. Kishore is a member of the American Association for the Advancement
of Science, the American Society of Biochemistry and Molecular Biology, the
American Society of Plant Physiologists, and the Institute of Food Technology.
He is a founder of the plant biotech/informatics company, Metahelix Life
Sciences. Dr. Kishore also serves as the chairperson for the St. Louis RCGA's
Bioenergy group. He serves on the boards of numerous "for profit" and "not-
for-profit" institutions including: the School of Nutrition and Policy, Tufts'
University, St.Louis RCGA, National Research Advisory Board of the Washington
University at St. Louis. He has also served as an advisor to National Science
Committees in many Asian countries and venture capital groups.
Burrill & Company
Founded in 1994, Burrill & Company has over $850 million in venture
capital funds under management and has an active merchant banking and media
business. The company's 50 person scientific and business team, supported by
its nearly 40-person Advisory Boards, the strategic and financial network of
its limited partners, and the close relationships developed with numerous life
science companies and management, provide Burrill with unparalleled access and
The Burrill Life Sciences Media Group LLC, a joint venture between
Burrill & Company and Nielsen Business Media, publishes a wide range of
biotechnology/life science bio-intelligence reports, the Journal of Life
Sciences, and is also the sponsor and facilitator of over a dozen leading
industry conferences. The annual book on the "State of the Industry" -- the
21st Edition -- entitled Biotech 2007-Life Sciences: A Global Transformation,
is now available. Full details may be found at: http://www.burrillandco.com/ .
For further information:
For further information: Peter Winter, Editorial Director, of Burrill &
Company, +1-415-591-5474, fax, +1-415-591-5401, firstname.lastname@example.org Web Site: